1981
DOI: 10.1111/j.1530-0277.1981.tb05354.x
|View full text |Cite
|
Sign up to set email alerts
|

The Disulfiram (Antabuse)‐Alcohol Reaction in Male Alcoholics: Its Efficient Management by 4‐Methylpyrazole

Abstract: 4-methylpyrazole (4-MP), an inhibitor of alcohol dehydrogenase, rapidly abolished the accumulation of acetaldehyde following alcohol ingestion both in volunteers pretreated with the Antabuse analog calcium carbimide and in an antabuse-treated alcoholic. 4-MP also attenuated other typical symptoms, including facial flushing and tachycardia, thus suggesting its usefulness in the acute treatment of severe disulfiram-alcohol reactions.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
15
0
1

Year Published

1984
1984
2017
2017

Publication Types

Select...
4
4
1

Relationship

0
9

Authors

Journals

citations
Cited by 70 publications
(17 citation statements)
references
References 16 publications
1
15
0
1
Order By: Relevance
“…A similar effect was found with 4-MP infusion into ALDH inhibitor-pretreated sub jects followed by ethanol intake (16,17 As to non-flushing Orientals and Cau casians possessing both the low-Km ALDH and another major ALDH isozyme found in every human with a higher Km value for AcH (22, 23), they appear to have a sufficient capacity for AcH oxidation to prevent hepatic AcH output under normal conditions, but there is not such a high capacity to cover the 50% increase in ethanol oxidation observed in Caucasian alcoholics (11 , 12). Therefore, in alcohol aversion therapy, partial inhibition of ALDH activity probably leads to a con dition similar to that of flushing Orientals who show significant accumulation of AcH during ethanol intoxication.…”
Section: Discussionsupporting
confidence: 54%
See 1 more Smart Citation
“…A similar effect was found with 4-MP infusion into ALDH inhibitor-pretreated sub jects followed by ethanol intake (16,17 As to non-flushing Orientals and Cau casians possessing both the low-Km ALDH and another major ALDH isozyme found in every human with a higher Km value for AcH (22, 23), they appear to have a sufficient capacity for AcH oxidation to prevent hepatic AcH output under normal conditions, but there is not such a high capacity to cover the 50% increase in ethanol oxidation observed in Caucasian alcoholics (11 , 12). Therefore, in alcohol aversion therapy, partial inhibition of ALDH activity probably leads to a con dition similar to that of flushing Orientals who show significant accumulation of AcH during ethanol intoxication.…”
Section: Discussionsupporting
confidence: 54%
“…On the contrary, reduction in the ethanol oxidation rate is often highly effective for alleviation of acute AcH toxicity in the subject pretreated with ALDH inhibitor. Partial inhibition of ethanol elimination by infusing a small dose of 4 methylpyrazole (4-MP), a specific inhibitor of alcohol dehydrogenase (13) with low toxicity (14,15), to cyanamide (another ALDH inhibitor)-treated subjects lead to a rapid fall in the level of AcH and associated responses (16,17). During the course of our previous experiment investigating AcH ac cumulation in relation to ethanol and AcH oxidizing capacity, 4-MP was found to be highly effective in reducing AcH levels also in flushing Orientals (18).…”
Section: Abstract-alcohol-sensitivementioning
confidence: 99%
“…During alcohol intake, substantial decreases in blood acetaldehyde levels with concomitant amelioration of acetaldehyde-related cardiovascular effects in response to 4-MP are found among white subjects with pharmacological ALDH-inhibition (Kupari et al, 1983;Lindros et al, 1981) and Asian subjects with inherited ALDH deficiency (Inoue et al, 1984). In the present study, the acetaldehyde level obtained during alcohol intoxication was indistinguishable from the acetaldehyde formed in vitro during sample processing; that is, we could find no evidence for the existence of free and loosely bound acetaldehyde in the peripheral venous blood during alcohol intoxication in white subjects.…”
Section: Discussionmentioning
confidence: 99%
“…They are most active against P450 2D6, where they have relative potency of paroxetine > flouxetine > sertraline, fluvoxamine > citalopram > venalafaxine, nefazodone, with K i s ranging from 0.07 to 33 M (Fig. 2.15a) [247][248][249][250]. Their inhibitory action, however, is not limited to P450 2D6.…”
Section: Interactions With Serotonin Selective Reuptake Inhibitorsmentioning
confidence: 99%